Articles From: Hercules Announces Third Quarter 2014 Financial Results and Quarterly Dividend of $0.31 per Share to Innocoll to Report Third Quarter 2014 Financial Results and Host Webcast and Conference Call on November 13, 2014


2014/11/6
Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and energy & renewable technology industries, at all stages of development, announced today its financial results for the third quarter ended September 30, 2014.
Sign-up for Hercules Announces Third Quarter 2014 Financial Results and Quarterly Dividend of $0.31 per Share investment picks
2014/11/6
Heron Therapeutics, Inc. (NASDAQ:HRTX), a biotechnology company, today disclosed a development program for a P/neurokinin-1 (NK 1 ) receptor antagonist, which is used in the prevention of both acute- and delayed-onset chemotherapy induced nausea and vomiting (CINV). NK 1 receptor antagonists are administered in combination with a 5-HT 3 receptor antagonist for the prevention of CINV.
Sign-up for Heron Therapeutics Discloses New Proprietary Intravenous Formulation of NK-1 Receptor Antagonist for Prevention of CINV investment picks
2014/11/6
Hilton Worldwide (NYSE: HLT) recently celebrated Global Week of Service, the company’s worldwide annual volunteer event.
Sign-up for Hilton Worldwide’s 2014 Global Week of Service Takes Place in 86 Countries investment picks
2014/11/6
MUSCATINE, Iowa , Nov.
Sign-up for HNI Corporation Announces Quarterly Dividend investment picks
2014/11/6
DUBLIN, IRELAND --
Sign-up for Horizon Pharma plc Appoints John J. Kody as Executive Vice President and Chief Commercial Officer investment picks
2014/11/6
-- Narrows full-year 2014 sales and earnings per share projections toward upper end of the range --
Sign-up for Hospira Reports Third-Quarter 2014 Results investment picks
2014/11/6
Global education leader Houghton Mifflin Harcourt Company (“HMH” or “the Company”) (NASDAQ: HMHC) today announced its financial results for the third quarter ended September 30, 2014 as well as an updated outlook for the full year 2014.
Sign-up for Houghton Mifflin Harcourt Company Announces Third Quarter 2014 Results investment picks
2014/11/6
RED BANK, N.J., Nov.
Sign-up for Hovnanian Enterprises' Presentation at the UBS Building and Building Products Annual CEO Conference to be Webcast Live investment picks
2014/11/6
By Priya Anand, MarketWatch Security researchers have found a new malware that targets Apple (AAPL) users in "the biggest scale we have ever seen" -- a sign that criminals are becoming more proficient at hacking Macs and iPhones.
Sign-up for How Apple users can protect themselves from WireLurker malware investment picks
2014/11/6
Hudson Technologies, Inc. (NASDAQ:HDSN) today announced the acquisition of the reclamation business and assets of Polar Technologies, a full service refrigeration reclaimer.
Sign-up for Hudson Technologies Announces Acquisition of Polar Technologies Reclamation Business investment picks
2014/11/6
Revenues Were $1.72 Billion for the Third Quarter of 2014 Segment Operating Margin for the Quarter Was 8.8 Percent Total Operating Margin Was 10.0 Percent, a 220 bps Improvement Over Q3 2013 Diluted Earnings Per Share Was $1.96 for the Quarter Cash and Cash Equivalents at the End of the Quarter Were $769 Million NEWPORT NEWS, Va., Nov.
Sign-up for Huntington Ingalls Industries Reports Third Quarter Results investment picks
2014/11/6
http://www.ccnmatthews.com/logos/20070205-main_husky_logo.jpg CALGARY, ALBERTA --
Sign-up for Husky Energy to Present at Bank of America Merrill Lynch Conference investment picks
2014/11/6
-- UCD Product Portfolio Generates $26.2 Million in Net Sales During the Quarter --
Sign-up for Hyperion Therapeutics Announces Third Quarter 2014 Financial Results investment picks
2014/11/6
WOODCLIFF LAKE, N.J., Nov.
Sign-up for I.D. Systems Reports 2014 Third Quarter and Nine Months Results investment picks
2014/11/6
ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded a project by the US Food & Drug Administration (FDA) to develop an industry-standard Patient Reported Outcome (PRO) measure that can be used in anti-bacterial drug development trials for hospital-acquired bacterial pneumonia (HABP). HABP is the second most common hospital-acquired infection and is the primary cause of death in intensive care units.
Sign-up for ICON Selected by the FDA to Develop New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials investment picks
2014/11/6
FREMONT, Calif., Nov.
Sign-up for Identiv to Hold Q3 2014 Earnings Webcast and Conference Call on November 13, 2014 investment picks
2014/11/6
CAMBRIDGE, Mass., Nov.
Sign-up for Idera Pharmaceuticals Announces Upcoming Presentations of Data From Oncology Programs at Key Scientific Meetings investment picks
2014/11/6
IDEX CORPORATION (NYSE:IEX) today announced its Board of Directors has approved an additional share repurchase authorization of up to $400 million of IDEX’s outstanding common shares.
Sign-up for IDEX Corporation Announces Additional Share Repurchase Authorization investment picks
2014/11/6
http://www.ccnmatthews.com/logos/20050803-IGMfinancial.jpg WINNIPEG, MANITOBA --
Sign-up for IGM Financial Inc. Reports Third Quarter Earnings: Increases Dividend investment picks
2014/11/6
Fiscal 2014 Results (compared to last year) - Total revenue decreased 12% to $2.1 billion - Social gaming revenue increased 28% to $281 million and average bookings per daily active user grew 16% to $0.43 - Adjusted earnings per share decreased 14% to $1.09 - GAAP earnings per share decreased 4% to $0.99 - Returned $319 million to shareholders in the form of share repurchases and dividends Fourth Quarter Results (compared to last year's fourth quarter) - Total revenue decreased 15% to $537 million - Social gaming revenue increased 22% to $75 million and average bookings per daily active user grew 15% to $0.46 - Adjusted earnings per share increased 23% to $0.37 - GAAP earnings per share increased 17% to $0.28 LAS VEGAS , Nov.
Sign-up for IGT Reports Fourth Quarter and Fiscal Year 2014 Results investment picks
2014/11/6
TOKYO, Nov.
Sign-up for IIJ Announces First Six Months Financial Results for the Fiscal Year Ending March 31, 2015 investment picks
2014/11/6
DULUTH, Minn., Nov.
Sign-up for IKONICS Reports Record Sales and a 20% Third Quarter Earnings Increase investment picks
2014/11/6
More than 37 IMBRUVICA Data Abstracts Will be Presented SUNNYVALE, Calif.
Sign-up for IMBRUVICA® (ibrutinib) Data to be Presented Across Multiple Histologies, Including in Eight Oral Presentations, at 2014 American Society of Hematology (ASH) Annual Meeting investment picks
2014/11/6
Imperial Holdings, Inc. (NYSE: IFT) (“Imperial”) announced today that it will host a conference call on Monday, November 10, 2014 at 5:00 p.m. ET to discuss the Company’s third quarter 2014 financial results.
Sign-up for Imperial Holdings, Inc. Announces Third Quarter 2014 Results Conference Call investment picks
2014/11/6
STAMFORD, Conn., Nov.
Sign-up for Independence Holding Company Announces 2014 Third-Quarter and Nine-Month Results investment picks
2014/11/6
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that new data for duvelisib (IPI-145), an oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, will be presented at the American Society of Hematology (ASH) 2014 Annual Meeting, which is being held December 6-9 in San Francisco, CA.
Sign-up for Infinity Announces Clinical and Preclincal Data for Duvelisib to Be Presented at ASH 2014 Annual Meeting investment picks
2014/11/6
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today reported its third quarter 2014 financial results and updated its 2014 financial guidance based on the commencement of its global strategic collaboration with AbbVie Inc. to develop and commercialize duvelisib (IPI-145), an oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in oncology.
Sign-up for Infinity Reports Third Quarter 2014 Financial Results and Provides Company Update investment picks
2014/11/6
BANGALORE, India , November 6, 2014 /PRNewswire/ -- Infosys, a global leader in technology, consulting, outsourcing and next generation services, today announced a strategic engineering partnership with DreamWorks Animation.
Sign-up for Infosys and DreamWorks Animation Join Hands to Engineer New Solutions investment picks
2014/11/6
ATHLONE, Ireland, Nov.
Sign-up for Innocoll to Report Third Quarter 2014 Financial Results and Host Webcast and Conference Call on November 13, 2014 investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Hercules Announces Third Quarter 2014 Financial Results and Quarterly Dividend of $0.31 per Share to Innocoll to Report Third Quarter 2014 Financial Results and Host Webcast and Conference Call on November 13, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent